Management of chronic severe pain

Cerebral neuromodulatory and neuroablative approaches

Research output: Chapter in Book/Report/Conference proceedingChapter

6 Citations (Scopus)

Abstract

Two approaches are utilized when targeting the brain to treat pain. The first, a non-destructive approach, uses either electrical stimulation of brain targets thought to modulate the process of pain perception, or pharmacological agents are introduced into ventricular spaces to target pain modulating receptors. Electrical stimulation targets include; the thalamic nuclei, the periventricular and periaqueductal grey (PVG and PAG) matter or the motor cortex. Currently, the pharmacological agent of choice for intracerebroventricular injection is morphine. In general, electrical stimulation is used for nonmalignant type pain, and pharmacological modulation for malignant type pain. The second, a destructive approach, is usually employed with the goal of interrupting the signals that lead to pain perception at various levels. Neuroablation is usually performed on cellular complexes such as "nuclei, or gyri" or on tracts with the aim of disrupting the sensory and limbic pathways involved in the emotional processes associated with pain. Specific cerebral neuroablation targets include; the thalamic medial group of nuclei, the cingulated gyrus, and the trigeminal nucleus and tract. There are fewer reports in the literature detailing the brain, when compared to the spine, as a target to treat pain, and further research is required.

Original languageEnglish (US)
Title of host publicationOperative Neuromodulation
Subtitle of host publicationVolume 2: Neural Networks Surgery
PublisherSpringer Wien
Pages17-26
Number of pages10
Edition97 PART 2
ISBN (Print)9783211330807
DOIs
StatePublished - Jan 1 2007

Publication series

NameActa Neurochirurgica, Supplementum
Number97 PART 2
ISSN (Print)0065-1419

Fingerprint

Chronic Pain
Pain
Pain Perception
Pharmacology
Electric Stimulation
Trigeminal Nuclei
Mediodorsal Thalamic Nucleus
Thalamic Nuclei
Periaqueductal Gray
Nociceptors
Deep Brain Stimulation
Motor Cortex
Brain
Morphine
Spine
Injections
Research

Keywords

  • central pain
  • cerebral chronic pain
  • neuroablation
  • Neuromodulation
  • neuropathic pain
  • neurostimulation
  • review

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Raslan, A., McCartney, S., & Burchiel, K. (2007). Management of chronic severe pain: Cerebral neuromodulatory and neuroablative approaches. In Operative Neuromodulation: Volume 2: Neural Networks Surgery (97 PART 2 ed., pp. 17-26). (Acta Neurochirurgica, Supplementum; No. 97 PART 2). Springer Wien. https://doi.org/10.1007/978-3-211-33081-4_2

Management of chronic severe pain : Cerebral neuromodulatory and neuroablative approaches. / Raslan, Ahmed; McCartney, Shirley; Burchiel, Kim.

Operative Neuromodulation: Volume 2: Neural Networks Surgery. 97 PART 2. ed. Springer Wien, 2007. p. 17-26 (Acta Neurochirurgica, Supplementum; No. 97 PART 2).

Research output: Chapter in Book/Report/Conference proceedingChapter

Raslan, A, McCartney, S & Burchiel, K 2007, Management of chronic severe pain: Cerebral neuromodulatory and neuroablative approaches. in Operative Neuromodulation: Volume 2: Neural Networks Surgery. 97 PART 2 edn, Acta Neurochirurgica, Supplementum, no. 97 PART 2, Springer Wien, pp. 17-26. https://doi.org/10.1007/978-3-211-33081-4_2
Raslan A, McCartney S, Burchiel K. Management of chronic severe pain: Cerebral neuromodulatory and neuroablative approaches. In Operative Neuromodulation: Volume 2: Neural Networks Surgery. 97 PART 2 ed. Springer Wien. 2007. p. 17-26. (Acta Neurochirurgica, Supplementum; 97 PART 2). https://doi.org/10.1007/978-3-211-33081-4_2
Raslan, Ahmed ; McCartney, Shirley ; Burchiel, Kim. / Management of chronic severe pain : Cerebral neuromodulatory and neuroablative approaches. Operative Neuromodulation: Volume 2: Neural Networks Surgery. 97 PART 2. ed. Springer Wien, 2007. pp. 17-26 (Acta Neurochirurgica, Supplementum; 97 PART 2).
@inbook{2d4212328a22438a8ada26b31091614e,
title = "Management of chronic severe pain: Cerebral neuromodulatory and neuroablative approaches",
abstract = "Two approaches are utilized when targeting the brain to treat pain. The first, a non-destructive approach, uses either electrical stimulation of brain targets thought to modulate the process of pain perception, or pharmacological agents are introduced into ventricular spaces to target pain modulating receptors. Electrical stimulation targets include; the thalamic nuclei, the periventricular and periaqueductal grey (PVG and PAG) matter or the motor cortex. Currently, the pharmacological agent of choice for intracerebroventricular injection is morphine. In general, electrical stimulation is used for nonmalignant type pain, and pharmacological modulation for malignant type pain. The second, a destructive approach, is usually employed with the goal of interrupting the signals that lead to pain perception at various levels. Neuroablation is usually performed on cellular complexes such as {"}nuclei, or gyri{"} or on tracts with the aim of disrupting the sensory and limbic pathways involved in the emotional processes associated with pain. Specific cerebral neuroablation targets include; the thalamic medial group of nuclei, the cingulated gyrus, and the trigeminal nucleus and tract. There are fewer reports in the literature detailing the brain, when compared to the spine, as a target to treat pain, and further research is required.",
keywords = "central pain, cerebral chronic pain, neuroablation, Neuromodulation, neuropathic pain, neurostimulation, review",
author = "Ahmed Raslan and Shirley McCartney and Kim Burchiel",
year = "2007",
month = "1",
day = "1",
doi = "10.1007/978-3-211-33081-4_2",
language = "English (US)",
isbn = "9783211330807",
series = "Acta Neurochirurgica, Supplementum",
publisher = "Springer Wien",
number = "97 PART 2",
pages = "17--26",
booktitle = "Operative Neuromodulation",
edition = "97 PART 2",

}

TY - CHAP

T1 - Management of chronic severe pain

T2 - Cerebral neuromodulatory and neuroablative approaches

AU - Raslan, Ahmed

AU - McCartney, Shirley

AU - Burchiel, Kim

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Two approaches are utilized when targeting the brain to treat pain. The first, a non-destructive approach, uses either electrical stimulation of brain targets thought to modulate the process of pain perception, or pharmacological agents are introduced into ventricular spaces to target pain modulating receptors. Electrical stimulation targets include; the thalamic nuclei, the periventricular and periaqueductal grey (PVG and PAG) matter or the motor cortex. Currently, the pharmacological agent of choice for intracerebroventricular injection is morphine. In general, electrical stimulation is used for nonmalignant type pain, and pharmacological modulation for malignant type pain. The second, a destructive approach, is usually employed with the goal of interrupting the signals that lead to pain perception at various levels. Neuroablation is usually performed on cellular complexes such as "nuclei, or gyri" or on tracts with the aim of disrupting the sensory and limbic pathways involved in the emotional processes associated with pain. Specific cerebral neuroablation targets include; the thalamic medial group of nuclei, the cingulated gyrus, and the trigeminal nucleus and tract. There are fewer reports in the literature detailing the brain, when compared to the spine, as a target to treat pain, and further research is required.

AB - Two approaches are utilized when targeting the brain to treat pain. The first, a non-destructive approach, uses either electrical stimulation of brain targets thought to modulate the process of pain perception, or pharmacological agents are introduced into ventricular spaces to target pain modulating receptors. Electrical stimulation targets include; the thalamic nuclei, the periventricular and periaqueductal grey (PVG and PAG) matter or the motor cortex. Currently, the pharmacological agent of choice for intracerebroventricular injection is morphine. In general, electrical stimulation is used for nonmalignant type pain, and pharmacological modulation for malignant type pain. The second, a destructive approach, is usually employed with the goal of interrupting the signals that lead to pain perception at various levels. Neuroablation is usually performed on cellular complexes such as "nuclei, or gyri" or on tracts with the aim of disrupting the sensory and limbic pathways involved in the emotional processes associated with pain. Specific cerebral neuroablation targets include; the thalamic medial group of nuclei, the cingulated gyrus, and the trigeminal nucleus and tract. There are fewer reports in the literature detailing the brain, when compared to the spine, as a target to treat pain, and further research is required.

KW - central pain

KW - cerebral chronic pain

KW - neuroablation

KW - Neuromodulation

KW - neuropathic pain

KW - neurostimulation

KW - review

UR - http://www.scopus.com/inward/record.url?scp=85052609251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052609251&partnerID=8YFLogxK

U2 - 10.1007/978-3-211-33081-4_2

DO - 10.1007/978-3-211-33081-4_2

M3 - Chapter

SN - 9783211330807

T3 - Acta Neurochirurgica, Supplementum

SP - 17

EP - 26

BT - Operative Neuromodulation

PB - Springer Wien

ER -